ITCI   $77.65  0.88% Market Closed After Close 77.61 -0.05%

Intra-Cellular Therapies Inc
Total Cash 1.02B
totalCashPerShare 9.68
EBITDA -111.95M
Total Debt 18.29M
quickRatio 7.224
currentRatio 7.815
Total Revenue 564.53M
debtToEquity 1.598
Revenue/Share 5.745
ROA -0.069120005
ROE -0.09625
grossProfits
freeCashflow 2.34M
operatingCashflow -60.91M
earningsGrowth
revenueGrowth 0.457
grossMargins 0.58827996
ebitdaMargins -0.19830999
operatingMargins -0.17177999
profitMargins -0.14934
enterpriseValue 7.13B
forwardPE 106.31506
floatShares 103.39M
sharesOutstanding 105.67M
sharesShort 2.43M
sharesShortPriorMonth 2.49M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.97%
Short Ratio help_outline 4.10%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 10.837
Price To Book help_outline 7.16
earningsQuarterlyGrowth
netIncomeToCommon -84.30M
trailingEps -0.86%
forwardEps 0.73%
enterpriseToEbitda -63.67
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.19 3Q 2024
institutionsCount 510
lastUpdated Sept. 21, 2024, 12:40 p.m.